Skip to main content
2024 CRT Conference Main banner
Back

Heart Failure

Heart Failure Innovation [Non-CME]

Heart Failure Innovation [Non-CME]

Monday, March 11, 2024
8:00 AM – 11:45 AM ET

    Program Director(s)

  • William Abraham, MD

    Professor of Medicine
    The Ohio State University
    Columbus, Ohio, United States

  • Farooq Sheikh, MD

    Medical Director, Advanced Heart Failure Program
    MedStar Health, Georgetown University School of Medicine
    Washington, District of Columbia, United States

Disclosure(s):
William T. Abraham, MD: Abbott: Advisor (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Impulse Dynamics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sensible Medical: Advisor (Ongoing); V-wave Medical: Consulting fees or other remuneration (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Zoll Respicardia: Advisor (Ongoing)
Farooq Sheikh, MD: AstraZeneca Pharmaceuticals: Clinical Trial Investigator (Ongoing); Regenxbio: Consultant (Ongoing)

Presentations:

  • 8:00 AM – 8:08 AM ET
    The Expanding World of Interventional Heart Failure

    Speaker: William T. Abraham, MD – The Ohio State University

  • 8:00 AM – 9:20 AM ET
    DEVICE INNOVATIONS FOR HEART FAILURE

    Moderator: Jennifer L. Carter, DPT – Medstar Washington Hospital Center

  • 8:08 AM – 8:16 AM ET
    Hemodynamic Monitoring as a Management Strategy for Patients with Heart Failure: Outcomes and Lessons Learned

    Speaker: William T. Abraham, MD – The Ohio State University

  • 8:16 AM – 8:24 AM ET
    Devices to Reverse Remodel the Dilated Failing Heart

    Speaker: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

  • 8:24 AM – 8:32 AM ET
    Exercise Prescription with Mechanical Circulatory Devices

    Speaker: Jennifer L. Carter, DPT – Medstar Washington Hospital Center

  • 8:32 AM – 8:40 AM ET
    ARIA Technology | Implantable Medical Device for Treating Pulmonary Hypertension

    Speaker: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

  • 8:40 AM – 8:48 AM ET
    Even Smaller but Higher Flow MCP (Magenta) Device

    Speaker: Horst Sievert, MD, FSCAI, FACC, FESC – CardioVascular Center Frankfurt CVC

  • 8:48 AM – 8:56 AM ET
    LV Reshaping for Heart Failure: The Revivent Procedure and the ALIVE Trial

    Speaker: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

  • 8:56 AM – 9:04 AM ET
    Magenta Elevate™ pLVAD - Breaking the Flow/Fr Size Ceiling: Hemodynamics and US Clinical Experience

    Speaker: David Israeli, MD – Magenta Medical Ltd.

  • 9:04 AM – 9:20 AM ET
    Panel Discussion | Challenges Designing Clinical Trials for Heart Failure Using the MCP Devices

    Panel Moderator: Jennifer L. Carter, DPT – Medstar Washington Hospital Center

    Panel Discussant: William T. Abraham, MD – The Ohio State University

    Panel Discussant: Ori Ben-Yehuda, MD – University of California, San Diego

    Panel Discussant: David F. Kong, MD, AM, DMT – Duke University

    Panel Discussant: Horst Sievert, MD, FSCAI, FACC, FESC – CardioVascular Center Frankfurt CVC

    Panel Discussant: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc

    Panel Discussant: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

    Panel Discussant: George W. Vetrovec, MD, MACC, MSCAI – VCU Pauley Heart Center

  • 9:20 AM – 9:28 AM ET
    Why do we need Definitions of Heart Failure?

    Speaker: Ileana L. Pina, MD, MPH – Thomas Jefferson University

  • 9:20 AM – 10:40 AM ET
    LV RECONSTRUCTION AND TREATMENT OF CARDIOMYOPATHIES

    Moderator: William T. Abraham, MD – The Ohio State University

    Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

    Moderator: Ileana L. Pina, MD, MPH – Thomas Jefferson University

  • 9:28 AM – 9:36 AM ET
    Cardiac Contractility Modulation for HFrEF and HFmrEF

    Speaker: William T. Abraham, MD – The Ohio State University

  • 9:36 AM – 9:44 AM ET
    LV Remodeling Using the Sling Procedure - Initial Results

    Speaker: Horst Sievert, MD, FSCAI, FACC, FESC – CardioVascular Center Frankfurt CVC

  • 9:44 AM – 9:52 AM ET
    Novel Ventricular Assist Device: Preliminary Results of SUPIRA

    Speaker: Alexandre A. Abizaid, MD, PhD – Incor

  • 9:52 AM – 10:00 AM ET
    Current Landscape of Venous PVADS for Treatment of Diuretic-Resistant Acute Heart Failure and CRS

    Speaker: Zvonimir Krajcer, MD – Texas Heart Center for Cardiovascular Care at Texas Heart Institute

  • 10:00 AM – 10:08 AM ET
    Long-Term Results with Current Durable LVAD Technology

    Speaker: Mark R. Hofmeyer, MD, FACC – MedStar Health

  • 10:08 AM – 10:16 AM ET
    Hemodynamics of PE: Modeling the RV

    Speaker: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

  • 10:16 AM – 10:24 AM ET
    Implantable Devices for Pulmonary Hypertension

    Speaker: William T. Abraham, MD – The Ohio State University

  • 10:24 AM – 10:32 AM ET
    Pulmonary Denervation for PAH

    Speaker: Ori Ben-Yehuda, MD – University of California, San Diego

  • 10:32 AM – 10:40 AM ET
    Left Ventricular Restoration in HFrEF: The AccuCinch System and CORCINCH-HF Pivotal Study

    Speaker: Jason Foerst, MD – Carilion Clinic

  • 10:40 AM – 10:48 AM ET
    State-of-the-Art Transcatheter Intra-Atrial Shunt Device for Treatment of Heart Failure

    Speaker: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute

  • 10:40 AM – 11:45 AM ET
    INTERATRIAL SHUNTS

    Moderator: William T. Abraham, MD – The Ohio State University

    Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

    Moderator: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute

  • 10:48 AM – 10:56 AM ET
    Anticipating RELIEVE-HF: The Pivotal Trial of the V-Wave Shunt

    Speaker: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

  • 10:56 AM – 11:04 AM ET
    Transcatheter Intra-Atrial Shunt Device for Treatment of Heart Failure: FDA Perspective

    Speaker: Victor Mondine, MSE – Food and Drug Administration

  • 11:04 AM – 11:12 AM ET
    What Did We Learn from the REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt Results?

    Speaker: William T. Abraham, MD – The Ohio State University

  • 11:12 AM – 11:20 AM ET
    A Novel Right-to-Right Shunt for HF

    Speaker: Stanton J. Rowe, PhD – NXT Biomedical

  • 11:20 AM – 11:45 AM ET
    Panel Discussion: What Does the Future Hold for Interatrial Shunts?

    Panel Moderator: William T. Abraham, MD – The Ohio State University

    Panel Moderator: Daniel Burkhoff, MD, PhD – Cardiovascular Research Foundation

    Panel Moderator: Megan Coylewright, MD, MPH – The Erlanger Heart and Lung Institute

    Panel Discussant: Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC – John Muir Health Cardiovascular Institute

    Panel Discussant: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center

    Panel Discussant: Victor Mondine, MSE – Food and Drug Administration

    Panel Discussant: Stanton J. Rowe, PhD – NXT Biomedical

    Panel Discussant: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai

  • 11:45 AM ET
    Adjourn